Comprehensive Engineering of Ionizable Lipid Nanoparticles and mRNA Elements for Next-Generation Vaccines

Feb 15, 2026ACS nano

Designing Improved Lipid Nanoparticles and mRNA Components for Next-Generation Vaccines

AI simplified

mRNA Technology on OpenScience ↗PubMed ↗DOI ↗

Abstract

The H9T6 lipid formulation achieved more than 3.5-fold higher dendritic-cell transfection than SM-102 at low doses.

A specific lipid composition of H9T6:DOPG:cholesterol:PEG (40:16:43.5:0.5 mol %) was identified for improved mRNA delivery.
More than 630,000 3' UTR variants were ranked by half-life, and over 68,000 5' UTR sequences were analyzed for ribosome loading.
The 5B-8 UTR scaffold outperformed existing UTRs from authorized mRNA vaccines in terms of antigen expression.
Encapsulation of 5B-8 mRNA in H9T6 lipid nanoparticles improved delivery to lymph nodes and suggested an albumin-mediated transport mechanism.
In mice, the formulation produced robust T helper 1 (Th1)-biased immune responses with low-microgram doses, influenced by UTR architecture and lipid composition.
Repeat-dose studies in rats up to 100 μg revealed only temporary effects without additional safety concerns.

AI simplified

Messenger RNA (mRNA) vaccines in lipid nanoparticles (LNPs) are effective, yet immunity can wane, and reactogenicity increases with dose. We integrate ionizable lipid design, LNP formulation, and untranslated region (UTR) tuning to improve potency at low doses. From a 96-member biodegradable ionizable lipid library, stereodefined H9T6 emerged as the lead ionizable lipid. Design of experiments (DoE) identified an H9T6:DOPG:cholesterol:PEG composition (40:16:43.5:0.5 mol %) that achieved more than 3.5-fold higher dendritic-cell transfection than SM-102, increased endosomal escape, and localized expression predominantly to the injection site. For UTRs, mechanism-linked pooled screens of synthetic, barcoded randomized libraries ranked more than 630,000 3' UTR variants by half-life in primary human nasal epithelial cells and more than 68,000 5' UTR sequences by ribosome loading via polysome profiling, followed by predefined sequence filters consistent with efficient scanning and start codon recognition. The resulting 5B-8 scaffold outperformed benchmark UTRs from authorized mRNA vaccines in peak and cumulative antigen expressionand. Encapsulation of 5B-8 mRNA in H9T6 LNPs enhanced lymph node delivery, and add-back plus receptor-blocking assays support an albumin-mediated transport mechanism. In mice, the formulation elicited strong T helper 1 (Th1)-biased humoral and cellular responses at low-microgram doses. Antibody magnitude depended primarily on UTR architecture, whereas T-cell responses reflected contributions from both the lipid and the UTR. Repeat-dose studies in rats up to 100 μg showed only transient, reversible findings without additional safety signals. These results outline a general framework for low-dose, lymph node-targeted mRNA vaccines that couples rational lipid design with mechanism-informed UTR selection. in vitro in vivo

Full Text

Full text is available at the source.

View full text (PDF) ↗View full text ↗

Comprehensive Engineering of Ionizable Lipid Nanoparticles and mRNA Elements for Next-Generation Vaccines

Abstract

Full Text

You found one interesting study. We’ll send the next 7.

what lands in your inbox each week:

Recent issues from the mrna technology brief

Abstract

Full Text

Related papers

You found one interesting study. We’ll send the next 7.

what lands in your inbox each week:

Recent issues from the mrna technology brief